Cowie, M. R., Filippatos, G. S., Alonso Garcia, M. d. l. A., Anker, S. D., Baczynska, A., Bloomfield, D. M., Borentain, M., Bruins Slot, K., Cronin, M., Doevendans, P. A., El‐Gazayerly, A., Gimpelewicz, C., Honarpour, N., Janmohamed, S., Janssen, H., Kim, A. M., Lautsch, D., Laws, I., Lefkowitz, M., Lopez‐Sendon, J., Lyon, A. R., Malik, F. I., McMurray, J. J., Metra, M., Figueroa Perez, S., Pfeffer, M. A., Pocock, S. J., Ponikowski, P., Prasad, K., Richard‐Lordereau, I., Roessig, L., Rosano, G. M., Sherman, W., Stough, W. G., Swedberg, K., Tyl, B., Zannad, F., Boulton, C., & De Graeff, P. (2017). new medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment. European journal of heart failure, 19, 718–727. http://access.bl.uk/ark:/81055/vdc_100046696386.0x000035